A Combined Neurofeedback-TMS Intervention for Alcohol Use Disorder
ConditionAlcohol Use Disorder
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age19-65
SponsorAuburn University
About this trial
The goal of this clinical study is to test the effectiveness of a supplemental fMRI neurofeedback and/or TMS intervention in individuals seeking treatment for Alcohol Use Disorder.
After an initial visit, participants will come in once a week for four (4) weeks for an intervention session, which may or may not include TMS and MRI. Participants will be contacted for monthly follow-ups (remotely) for up to 12 months and will be asked to come in for two MRI follow-ups at 6 and 12 months.
Eligibility criteria
Qualifiers
Age 19-65
Receiving treatment for Alcohol Use Disorder
Disqualifiers
MRI Contraindications
Presence of metal in the body that would make having a 7T MRI unsafe (including facial tattoos)
Claustrophobia, such that individual would be unable to stay in the MRI for up to 1 hr
Hearing loss, including tinnitus, that might be made worse by MRI or TMS
Trial design
Treatments tested in this trial
- Realtime fMRI Neurofeedback - Active
- TMS - Active
- Realtime fMRI Neurofeedback - Yoked Sham
- TMS - Sham
Treatment groups
90 Participants
are divided into 5 treatment groupsSponsors and collaborators
Auburn University
Lead sponsor
National Institute on Alcohol Abuse and Alcoholism (NIAAA)
Collaborator
Source ClinicalTrials.gov